Philip Home

发表

The path for medical associations to sponsor trustworthy guidelines: is it feasible?

N. Freemantle, J. Ledermann, G. Curigliano, 2022, Journal of the Royal Society of Medicine.

Philip Home, 2023, The lancet. Diabetes & endocrinology.

Composing a new IDF triennium: the beat goes on. . . . 2

R. Mazze, C. Stehouwer, C. Guldener, 2003 .

Rapid-acting insulin secretagogues: a clinical need?

P. Home, Philip Home, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial

A. Lindholm, P. Home, A. Riis, 2000, Diabetic medicine : a journal of the British Diabetic Association.

Rosiglitazone RECORD study: glucose control outcomes at 18 months

M. Hanefeld, S. Pocock, M. Komajda, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Monitoring the Targets of the St Vincent Declaration and the Implementation of Quality Management in Diabetes Care: the DiabCare Initiative

P. Home, K. Piwernetz, O. Snorgaard, 1993, Diabetic medicine : a journal of the British Diabetic Association.

A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes

N. Freemantle, B. Balkau, P. Home, 2013, Diabetes, obesity & metabolism.

Impact of the UKPDS—an overview

P. Home, Philip Home, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Circulating endothelial progenitor cells, endothelial function, carotid intima–media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria

P. Home, J. Weaver, L. Sibal, 2009, Diabetologia.

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

R. Bergenstal, M. Riddle, G. Bolli, 2015, Diabetes, obesity and metabolism.

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

B. Boehm, A. Lindholm, N. Kamp, 2002, Diabetic medicine : a journal of the British Diabetic Association.

Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?

P. D. Home, Philip Home, P. Home, 2015, Diabetes, obesity & metabolism.

Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK

A. McMahon, P. Home, G. Hall, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Intensive insulin therapy in clinical practice

P. D. Home, Philip Home, P. Home, 1997, Diabetologia.

The pharmacokinetics and pharmacodynamics of rapid‐acting insulin analogues and their clinical consequences

P. D. Home, P. D. Home, Philip Home, 2012, Diabetes, obesity & metabolism.

Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

M. Massi-Benedetti, A. Fritsche, P. Home, 2010, Diabetes, obesity and metabolism.

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials

A. Farmer, R. Holman, R. Ali, 2012, Diabetologia.

L. Heinemann, P. Home, M. Hompesch, 2015, Diabetes, obesity & metabolism.

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials

A. Farmer, R. Holman, R. Ali, 2012, Diabetologia.

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol

M. Hanefeld, S. Pocock, M. Komajda, 2005, Diabetologia.

Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo‐controlled trial

U. Dashora, L. Sibal, S. Ashwell, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes

S. Heller, R. Bilous, D. Hepburn, 2006, Diabetic medicine : a journal of the British Diabetic Association.

A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes

P. Home, A. Dressler, R. Rosskamp, 2005, Diabetes/metabolism research and reviews.

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

M. Riddle, H. Yki-Järvinen, G. Bolli, 2015, Diabetes, obesity & metabolism.

Doubts about DOTS

S. Ross, J. McLay, Philip Home, 2008, BMJ : British Medical Journal.

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study

P. Home, J. Gordon, P. McEwan, 2010, International journal of clinical practice.

From muck to molecule: insulin discovery over 50 years

Philip Home, 2022, British Journal of Diabetes.